➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School

Last Updated: September 24, 2020

DrugPatentWatch Database Preview


➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Flavoxate Hydrochloride patents expire, and what generic alternatives are available?

Flavoxate Hydrochloride is a drug marketed by Epic Pharma, Impax Pharms, and Paddock Llc. and is included in three NDAs.

The generic ingredient in FLAVOXATE HYDROCHLORIDE is flavoxate hydrochloride. There are eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the flavoxate hydrochloride profile page.

US ANDA Litigation and Generic Entry Outlook for Flavoxate Hydrochloride

A generic version of FLAVOXATE HYDROCHLORIDE was approved as flavoxate hydrochloride by PADDOCK LLC on December 16th, 2004.

  Start Trial

Drug patent expirations by year for FLAVOXATE HYDROCHLORIDE
Recent Clinical Trials for FLAVOXATE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

University of CalgaryPhase 4
Mahidol UniversityPhase 4
Paddock Laboratories, Inc.Phase 1

See all FLAVOXATE HYDROCHLORIDE clinical trials

Medical Subject Heading (MeSH) Categories for FLAVOXATE HYDROCHLORIDE

US Patents and Regulatory Information for FLAVOXATE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Epic Pharma FLAVOXATE HYDROCHLORIDE flavoxate hydrochloride TABLET;ORAL 076835-001 Nov 30, 2005 AB RX No No   Start Trial   Start Trial   Start Trial
Impax Pharms FLAVOXATE HYDROCHLORIDE flavoxate hydrochloride TABLET;ORAL 076234-001 Aug 28, 2003 DISCN No No   Start Trial   Start Trial   Start Trial
Paddock Llc FLAVOXATE HYDROCHLORIDE flavoxate hydrochloride TABLET;ORAL 076831-001 Dec 16, 2004 AB RX No Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.